Clinical Trial

Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

Name: Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine — clinical trial record (NCT06974617)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated May 16, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.

Summary

This trial compares the efficacy and safety of sphenopalatine ganglion block (SPGB) and intramuscular BOTOX injection in chronic migraine.

Trial Details

NCT Number	NCT06974617
Lead Sponsor	Cairo University
Conditions	Sphenopalatine Block, BOTOX, Chronic Migraine
Enrollment	64 participants
Start Date	2025-05-15
Primary Completion	2025-10-01 (estimated)
Study Completion	2025-10-01 (estimated)
Updated on ClinicalTrials.gov	2025-05-16